Sharemaestro company-news research for UnitedHealth Group Incorporated (UNH), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.

NYSE United States Measured evidence

Company news sentiment

UNH news sentiment

UnitedHealth Group Incorporated

Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.

30-day score61Neutral is 50
Constructive news tone 74/100 evidence confidence 97% direct company focus 108 current stories across 47 publishers
Latest weekly closeUSD 407.08week of 7 Aug 2026
Main news subjectEarnings84/100 share of current news
News data statusHealthy50 duplicate stories removed

Current company news

Constructive news tone

The score uses 108 current company stories from 47 publishers.

Observed headline tone62/100 Published 30-day score61/100

Older, less relevant and less reliable stories count for less. Confidence is shown separately.

Latest source headline UnitedHealth Group (UNH) officer uses 233 shares to cover equity-related costs Stock Titan · 13 Aug 2026 22:22

What supports the score

Direct evidence

108 current stories are mapped specifically to UNH.

Source breadth

The score uses 47 publishers rather than depending on one outlet.

Story agreement

The current stories agree at 77/100.

What limits the score

Price disagreement

Constructive headlines are not being rewarded by price, which raises a rejection flag.

61/100
News scoreConstructive news tone
74/100
Confidencesolid confidence
97%/100
Company news108 company stories
77/100
Story agreement23/100 difference

News history

Daily score and story count over 30 days

Daily weighted evidence
16 Jul: 10 stories17 Jul: 7 stories19 Jul: 1 stories20 Jul: 4 stories21 Jul: 5 stories22 Jul: 3 stories23 Jul: 2 stories24 Jul: 7 stories25 Jul: 3 stories26 Jul: 1 stories27 Jul: 4 stories28 Jul: 2 stories29 Jul: 7 stories30 Jul: 3 stories31 Jul: 1 stories02 Aug: 2 stories03 Aug: 3 stories04 Aug: 2 stories05 Aug: 2 stories06 Aug: 1 stories07 Aug: 1 stories08 Aug: 6 stories09 Aug: 2 stories10 Aug: 5 stories11 Aug: 5 stories12 Aug: 8 stories13 Aug: 5 stories 16 Jul: tone 80, 10 stories17 Jul: tone 83, 7 stories19 Jul: tone 43, 1 stories20 Jul: tone 71, 4 stories21 Jul: tone 66, 5 stories22 Jul: tone 55, 3 stories23 Jul: tone 82, 2 stories24 Jul: tone 71, 7 stories25 Jul: tone 66, 3 stories26 Jul: tone 80, 1 stories27 Jul: tone 73, 4 stories28 Jul: tone 76, 2 stories29 Jul: tone 80, 7 stories30 Jul: tone 65, 3 stories31 Jul: tone 56, 1 stories02 Aug: tone 79, 2 stories03 Aug: tone 48, 3 stories04 Aug: tone 24, 2 stories05 Aug: tone 84, 2 stories06 Aug: tone 50, 1 stories07 Aug: tone 50, 1 stories08 Aug: tone 72, 6 stories09 Aug: tone 50, 2 stories10 Aug: tone 70, 5 stories11 Aug: tone 80, 5 stories12 Aug: tone 72, 8 stories13 Aug: tone 26, 5 stories 95505
16 Jul31 Jul14 Aug
News scoreStory count50 baseline

Confidence

How reliable the score is

Separate from direction

Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.

Amount of evidence100
5.841 after freshness weighting
Source breadth100
47 independent publishers
Company relevance97
share tied directly to this company
Freshness59
recency-weighted evidence
Agreement77
how closely stories agree
Publisher mix86
less reliance on one publisher

Price and news history

News score and weekly price over 26 weeks

Positive news being faded

Constructive headlines are not being rewarded by price, which raises a rejection flag.

One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
13 Feb 2026: close 289.23, indexed 100.020 Feb 2026: close 286.08, indexed 98.927 Feb 2026: close 289.31, indexed 100.006 Mar 2026: close 282.61, indexed 97.713 Mar 2026: close 280.43, indexed 97.020 Mar 2026: close 273.97, indexed 94.727 Mar 2026: close 257.5, indexed 89.003 Apr 2026: close 275.63, indexed 95.310 Apr 2026: close 302.54, indexed 104.617 Apr 2026: close 322.73, indexed 111.624 Apr 2026: close 352.93, indexed 122.001 May 2026: close 366.71, indexed 126.808 May 2026: close 377.85, indexed 130.615 May 2026: close 391.64, indexed 135.422 May 2026: close 386.29, indexed 133.629 May 2026: close 378.18, indexed 130.805 Jun 2026: close 397.23, indexed 137.312 Jun 2026: close 406.23, indexed 140.519 Jun 2026: close 400.96, indexed 138.626 Jun 2026: close 427.89, indexed 147.903 Jul 2026: close 425.36, indexed 147.110 Jul 2026: close 424.62, indexed 146.817 Jul 2026: close 426.09, indexed 147.324 Jul 2026: close 420.74, indexed 145.531 Jul 2026: close 414.4, indexed 143.307 Aug 2026: close 407.08, indexed 140.7 19 Jun 2026: news score 50, close 400.96, 2 stories5026 Jun 2026: news score 50, close 427.89, 14 stories03 Jul 2026: news score 51, close 425.36, 25 stories5110 Jul 2026: news score 50, close 424.62, 33 stories17 Jul 2026: news score 71, close 426.09, 57 stories7124 Jul 2026: news score 68, close 420.74, 71 stories31 Jul 2026: news score 67, close 414.4, 82 stories6707 Aug 2026: news score 61, close 407.08, 84 stories61
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
26-week price+40.7%latest close 407.08
News score change+11first to latest comparable week
One-week response-1.8%Price digesting
Fair-value position-4.9%Near fair-value range
WeekNews scoreCloseWeekly move
07 Aug 202661USD 407.08-1.8%
31 Jul 202667USD 414.4-1.5%
24 Jul 202668USD 420.74-1.3%
17 Jul 202671USD 426.09+0.3%
10 Jul 202650USD 424.62-0.2%
03 Jul 202651USD 425.36-0.6%
26 Jun 202650USD 427.89+6.7%
19 Jun 202650USD 400.96-1.3%
Sentiment confirms active trend

News subjects

What is shaping the score

Earnings
Earnings7475 stories · 69%
Market update5012 stories · 11%
Analyst action817 stories · 6%
Regulatory and legal265 stories · 5%
Deals and strategy263 stories · 3%
Capital return563 stories · 3%
Guidance792 stories · 2%

Source mix

Where the evidence comes from

86/100 independence
MarketBeat7811 stories · 10%
Ad-hoc-news.de796 stories · 6%
Market source776 stories · 6%
Yahoo! Finance Canada795 stories · 5%
TradingKey775 stories · 5%
TradingView735 stories · 5%
AD HOC NEWS675 stories · 5%

Recurring subjects

Subjects appearing most often

Current evidence
Life Sciences91Earnings79Financial Markets63Finance59Economy Macro14Technology8Healthcare3HEALTHCARE3Economy Fiscal3Mergers And Acquisitions2

Earlier readings

How the score has changed

50 comparable readings · 56 days
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
Comparable move+950 to 59 · Strengthening
Observed range49–7150 is the neutral baseline
Evidence depth117stories at latest stored reading · +116
Confidence69/100Measured · +43
18 Jun50 neutral14 Aug 01:38
ConstructiveBalanced or withheldCautious

Changes in the stored score

Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.

ObservedScoreMoveConfidenceStoriesStatus
14 Aug 01:3859+069/100 (-1)117 (0)Measured
13 Aug 23:5959-870/100 (0)117 (+5)Measured
12 Aug 23:5967+070/100 (+7)112 (+11)Measured
11 Aug 23:5967+463/100 (+8)101 (+6)Measured
10 Aug 23:5963+055/100 (+2)95 (+5)Measured
09 Aug 23:5963-153/100 (-3)90 (+2)Measured
08 Aug 23:5964+356/100 (+7)88 (+4)Measured
07 Aug 23:5961-149/100 (-2)84 (0)Measured

Source headlines

The news behind the score

Showing 1-30 of the newest 90 · 108 current

Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.

#150Tone
Stock TitanDirect company coverageStored article

UnitedHealth Group (UNH) officer uses 233 shares to cover equity-related costs

UnitedHealth Group's Chief Accounting Officer, Dennis Andrew Stankiewicz, reported a Form 4 transaction where 233.402 shares of common stock were delivered or withheld at $402.19 per share to cover equity-related costs or tax liability. Following this transaction, Stankiewicz directly holds 10,057.567 shares, which include those from the company's Employee Stock Purchase Plan. The filing has been categorized as neutral in terms of its impact and sentiment.

FinanceLife Sciences
Published
13 Aug 2026 22:22
News subject
Market update
Why this score
No clear positive or negative phrase
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 1% · 0.2d old
Duplicates
1 consolidated
#225Tone
BenzingaDirect company coverageStored article

What's Going On With UnitedHealth Group Stock Thursday? - UnitedHealth Group (NYSE:UNH)

A derivative lawsuit has been filed against UnitedHealth Group's current and former leadership, alleging corporate governance breaches, Medicare fraud, and algorithmic care denials that led to significant stockholder value loss. The lawsuit also claims executives sold over $237 million in stock while material misconduct remained undisclosed. These allegations point to a period of financial turmoil for the company, including inflated Medicare Advantage revenue, systematic care denials, and significant insider stock sales.

EarningsFinanceLife SciencesFinancial Markets
Published
13 Aug 2026 18:27
News subject
Regulatory and legal
Why this score
Legal or regulatory risk
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 5.8% · 0.3d old
Duplicates
1 consolidated
#323Tone
Seeking AlphaDirect company coverageStored article

UnitedHealth faces shareholder suit accusing corporate governance failures

UnitedHealth Group is facing an amended shareholder lawsuit alleging that the company was aware of significant corporate governance issues but failed to address them. The lawsuit claims that these failures resulted in substantial losses in the company's stock value. The suit was filed in a Minnesota federal court.

EarningsFinanceGovernanceLife SciencesMedicareShareholder
Published
13 Aug 2026 14:18
News subject
Regulatory and legal
Why this score
Legal or regulatory risk
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 6% · 0.5d old
Duplicates
2 consolidated
#420Tone
Insurance JournalDirect company coverageStored article

UnitedHealth Investor Suit Alleges Security, Governance Lapses

A new shareholder lawsuit alleges that UnitedHealth Group Inc. board members ignored significant governance and oversight risks for years, leading to billions in investor losses. The amended complaint reveals details from former insiders about lax cybersecurity practices following the acquisition of Change Healthcare, which later suffered the largest US healthcare data breach, and alleges UnitedHealth shut down an internal audit program that found issues with Medicare billing. The company is facing multiple lawsuits and investigations concerning its Medicare practices and cybersecurity failures.

EarningsFinanceLife SciencesTechnology
Published
13 Aug 2026 13:02
News subject
Deals and strategy
Why this score
Legal or regulatory risk, Operational disruption
Company focus
Shared story · 78%
How it is used
Direct company coverage
Weighted influence
Low · 3.6% · 0.6d old
Duplicates
2 consolidated
#530Tone
Modern HealthcareDirect company coverageStored article

Investor lawsuit alleges UnitedHealth ignored Medicare, cyber risks

A lawsuit filed by an investor alleges that UnitedHealth Group ignored significant risks related to Medicare Advantage and cybersecurity. The suit claims that the company's board failed to address issues that could harm the company. This comes after recent cybersecurity incidents affecting UnitedHealth.

Life Sciences
Published
13 Aug 2026 10:02
News subject
Regulatory and legal
Why this score
Legal or regulatory risk
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 4.2% · 0.7d old
Duplicates
1 consolidated
#686Tone
MarketBeatDirect company coverageStored article

UnitedHealth Group Incorporated (NYSE:UNH) to Issue Quarterly Dividend of $2.32

UnitedHealth Group (NYSE:UNH) announced a quarterly dividend of $2.32 per share, payable on September 22nd to shareholders of record on September 14th. This represents an annualized payout of $9.28 and a 2.3% yield, with the dividend being well-covered by earnings at a 35.4% payout ratio. The company has a history of increasing its dividend for 15 consecutive years and reported strong quarterly EPS and revenue that exceeded analyst estimates.

EarningsLife SciencesFinancial MarketsFinance
Published
12 Aug 2026 22:52
News subject
Earnings
Why this score
Beat expectations, Operating growth
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 5.5% · 1.2d old
Duplicates
1 consolidated
#750Tone
seekingalpha.comDirect company coverageScored from headlineSource lookup

UnitedHealth declares $2.32 dividend

Published
12 Aug 2026 11:38
News subject
Capital return
Why this score
No clear positive or negative phrase
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 1.1% · 1.6d old
Duplicates
1 consolidated
#850Tone
seekingalpha.comDirect company coverageScored from headlineSource lookup

UnitedHealth declares $2.32 dividend

Published
12 Aug 2026 11:38
News subject
Capital return
Why this score
No clear positive or negative phrase
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 1.3% · 1.6d old
Duplicates
1 consolidated
#963Tone
seekingalpha.comDirect company coverageStored article

UnitedHealth declares $2.32 dividend

* UnitedHealth (UNH [https://seekingalpha.com/symbol/UNH]) declares $2.32/share quarterly dividend [https://seekingalpha.com/pr/20616162-unitedhealth-group-board-authorizes-payment-of-quarterly-dividend], in line with previous. * Forward yield [https://seekingalpha.com/symbol/UNH/dividends/yield?source=news_bullet] 2.31% * Payable Sept. 22; for shareholders of record Sept. 14; ex-div Sept. 14. * See UNH Dividend Scorecard, Yield Chart, & Dividend Growth. [https://seekingalpha.com/symbol/UNH/dividends?source=news_bullet] MORE ON UNITEDHEALTH * UnitedHealth's Medicare Recovery Is Accelerating An

Dividend Stocks NewsDividends
Published
12 Aug 2026 11:04
News subject
Capital return
Why this score
Positive financial language
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 2.1% · 1.6d old
Duplicates
1 consolidated
#1057Tone
finance.yahoo.comDirect company coverageStored article

UnitedHealth Group Board Authorizes Payment of Quarterly Dividend

August 12, 2026--(BUSINESS WIRE)--The UnitedHealth Group (NYSE: UNH) board of directors has authorized payment of a cash dividend of $2.32 per share, to be paid on September 22, 2026, to all shareholders of record of UNH common stock as of the close of business September 14, 2026. About UnitedHealth Group UnitedHealth Group (NYSE: UNH) is a healthcare and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering peo

DIVIDENDSDividendsEarningsFinanceHEALTHCAREHealthcare
Published
12 Aug 2026 11:00
News subject
Earnings
Why this score
Positive financial language
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 1.7% · 1.7d old
Duplicates
2 consolidated
#1163Tone
www.marketscreener.comDirect company coverageStored article

UnitedHealth Group Keeps Quarterly Dividend at $2.32 a Share, Payable Sept. 22 to Shareholders of Record as of Sept. 14

UnitedHealth Group (UNH) announced it will maintain its quarterly dividend at $2.32 per share. The dividend is payable on September 22 to shareholders of record as of September 14. This article, published on MarketScreener, provides details on the dividend and other recent news concerning the company.

EarningsLife SciencesFinance
Published
12 Aug 2026 11:38
News subject
Earnings
Why this score
Positive financial language
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 2.3% · 1.6d old
Duplicates
1 consolidated
#1281Tone
MarketBeatDirect company coverageStored article

UnitedHealth Group Incorporated $UNH Shares Bought by Annex Advisory Services LLC

Annex Advisory Services LLC significantly increased its stake in UnitedHealth Group (UNH) by 159.6% in the second quarter, bringing its total holdings to 68,577 shares valued at $28.5 million. This comes as UnitedHealth reported strong quarterly earnings of $6.38 per share, exceeding estimates, and raised its quarterly dividend to $2.32 per share. Despite a slight dip in share price, analysts maintain a "Moderate Buy" rating with a target price of $455.92.

EarningsLife SciencesFinancial MarketsFinance
Published
12 Aug 2026 08:05
News subject
Earnings
Why this score
Operating growth, Capital returned, Institutional or insider buying
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 5% · 1.8d old
Duplicates
1 consolidated
#1368Tone
MarketBeatDirect company coverageStored article

UnitedHealth Group Incorporated $UNH Shares Sold by Bay Colony Advisory Group Inc d b a Bay Colony Advisors

Bay Colony Advisory Group Inc. significantly reduced its stake in UnitedHealth Group ($UNH) by 64.9% in the second quarter, selling 3,037 shares and retaining 1,646 shares valued at $684,000. Despite this reduction, major institutional investors like Vanguard, State Street, and Capital World Investors increased their holdings, with institutional investors collectively owning 87.86% of UNH. UnitedHealth also reported strong quarterly earnings, exceeding consensus estimates, and raised its quarterly dividend to $2.32 per share, while analysts maintain a "Moderate Buy" consensus rating.

EarningsFinanceLife SciencesFinancial Markets
Published
12 Aug 2026 07:41
News subject
Earnings
Why this score
Operating growth, Capital returned, Institutional or insider selling
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 3.7% · 1.8d old
Duplicates
1 consolidated
#1450Tone
simplywall.stDirect company coverageScored from headlineSource lookup

UnitedHealth (UNH) Stock Slips As Medical Cost Fears Mute Profit Rebound

Published
11 Aug 2026 22:32
News subject
Earnings
Why this score
No clear positive or negative phrase
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 1% · 2.2d old
Duplicates
1 consolidated
#1589Tone
Seeking AlphaDirect company coverageStored article

UnitedHealth’s Medicare Recovery Is Accelerating And Has More Room To Run (NYSE:UNH)

UnitedHealth's Medicare Advantage operations are showing strong recovery, with cost trends below original assumptions and 2026 Medicare margins expected to exceed 3%. The company has raised its operating earnings outlook for UnitedHealthcare to at least $12 billion and adjusted EPS guidance to $19.50–$20. Despite a key risk from commercial medical cost trends above 11%, the company's robust quarterly operating cash flow supports significant buybacks and increased dividend payments, indicating further growth potential.

EarningsLife SciencesFinancial MarketsFinance
Published
11 Aug 2026 17:43
News subject
Earnings
Why this score
Guidance raised, Operating growth
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 6.1% · 2.4d old
Duplicates
1 consolidated
#1681Tone
MarketBeatDirect company coverageStored article

UnitedHealth Group Incorporated $UNH Stock Position Raised by Generali Investments Management Co LLC

Generali Investments Management Co LLC increased its stake in UnitedHealth Group (UNH) by 80.7% in Q2, bringing its total holdings to 9,024 shares valued at $3.75 million. UnitedHealth reported strong quarterly earnings, beating estimates, with revenue of $112.03 billion and a raised quarterly dividend of $2.32 per share. Analysts maintain a "Moderate Buy" rating for UNH with an average price target of $455.92.

EarningsLife SciencesFinancial MarketsFinance
Published
11 Aug 2026 10:30
News subject
Earnings
Why this score
Operating growth, Capital returned, Institutional or insider buying
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 4.4% · 2.7d old
Duplicates
1 consolidated
#1772Tone
MarketBeatDirect company coverageStored article

KMG Fiduciary Partners LLC Has $3.72 Million Stock Position in UnitedHealth Group Incorporated $UNH

KMG Fiduciary Partners LLC significantly reduced its stake in UnitedHealth Group (UNH) by 55.4% in the second quarter, selling over 11,000 shares but retaining 8,955 shares valued at $3.72 million. Despite this, UnitedHealth Group reported strong earnings, exceeding analyst estimates with quarterly EPS of $6.38 and revenue of $112.03 billion, and increased its quarterly dividend. Institutional investors hold a substantial 87.86% of UNH stock, and analysts maintain a "Moderate Buy" consensus with an average price target of $455.92.

EarningsFinancial MarketsLife SciencesFinance
Published
11 Aug 2026 10:05
News subject
Earnings
Why this score
Operating growth
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 2.8% · 2.7d old
Duplicates
1 consolidated
#1878Tone
Barchart.comDirect company coverageStored article

UnitedHealth Group Stock Outlook: Is Wall Street Bullish or Bearish?

UnitedHealth Group (UNH) has significantly outperformed the S&P 500 and the healthcare sector ETF (XLV) over the past year and in 2026, driven by stronger-than-expected Q2 2026 earnings and improved operating margins. Analysts maintain a "Strong Buy" consensus for UNH, with price targets indicating substantial upside potential, reflecting Wall Street's bullish sentiment on the healthcare giant.

EarningsFinancial MarketsLife Sciences
Published
11 Aug 2026 09:54
News subject
Earnings
Why this score
Operating growth, Positive valuation view
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 3.8% · 2.7d old
Duplicates
1 consolidated
#1950Tone
finance.yahoo.comDirect company coverageStored article

Elizabeth Warren Says UnitedHealth, CVS Have Too Much Control Over US Healthcare—Now She Wants to Break Up the Vertical Integration

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Sen. Elizabeth Warren (D-Mass) has criticized the vertical integration in the U.S. healthcare system, arguing that it leads to higher costs for patients and increased profits for large corporations. Warren took to X on Sunday and used UnitedHealth Group Inc. as an example of a company that controls multiple aspects of healthcare, including insurance, pharmacies, and providers. She argued that this consolidation leads to higher costs for patients while increasing corporate profits. She explained

Economy FiscalFinanceHEALTHCAREHealthcareLife SciencesREGULATION
Published
10 Aug 2026 22:31
News subject
Market update
Why this score
No clear positive or negative phrase
Company focus
Shared story · 78%
How it is used
Direct company coverage
Weighted influence
Low · 0.2% · 3.2d old
Duplicates
2 consolidated
#2072Tone
TradingViewDirect company coverageStored article

UnitedHealth Group 2Q 2026: Revenue $112B, EPS $6.04— 10-Q Summary

UnitedHealth Group reported its second-quarter 2026 results, showing flat revenue year-over-year at $112 billion, but significantly higher earnings. Net income attributable to common shareholders increased to $5.48 billion, and diluted EPS rose to $6.04. The company experienced a decline in UnitedHealthcare membership and an Optum realignment, including portfolio divestitures and a contraction in its value-based care footprint.

EarningsLife Sciences
Published
10 Aug 2026 20:09
News subject
Earnings
Why this score
Improving financial comparison, Operating growth
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 3% · 3.3d old
Duplicates
1 consolidated
#2150Tone
BenzingaDirect company coverageStored article

4 Health Care Stocks With Whale Alerts In Today’s Session

This article highlights unusual options activity, known as "whale alerts," for four health care stocks: UnitedHealth Group (UNH), Pfizer (PFE), Humana (HUM), and Novo Nordisk (NVO). It details specific call and put option trades with their associated sentiment, expiration dates, strike prices, and financial figures. The alerts are based on large options transactions that often indicate potential trading opportunities for investors.

Financial MarketsLife Sciences
Published
10 Aug 2026 17:35
News subject
Market update
Why this score
No clear positive or negative phrase
Company focus
Company discussed · 86%
How it is used
Direct company coverage
Weighted influence
Low · 0.3% · 3.4d old
Duplicates
1 consolidated
#2250Tone
Kalkine MediaDirect company coverageStored article

UnitedHealth Group (NYSE:UNH): Can Operational Strength Drive Growth?

This article from Kalkine Media discusses whether UnitedHealth Group's operational strength can drive its growth. It appears to be a premium content piece requiring login or registration to read the full analysis. The article is part of a series covering healthcare stocks and their market relevance.

EarningsLife SciencesFinance
Published
10 Aug 2026 09:11
News subject
Earnings
Why this score
No clear positive or negative phrase
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 1% · 3.7d old
Duplicates
1 consolidated
#2378Tone
MarketBeatDirect company coverageStored article

Seilern Investment Management Ltd Reduces Stock Position in UnitedHealth Group Incorporated $UNH

Seilern Investment Management Ltd significantly reduced its stake in UnitedHealth Group Incorporated by 43.1% in the second quarter, selling 121,096 shares but still retaining 160,023 shares valued at $66.5 million, making it their second-largest holding. Despite this reduction and a small insider sale by the CEO, UnitedHealth reported strong quarterly earnings and revenue, beating estimates, and increased its quarterly dividend. Analyst sentiment remains largely positive, with a "Moderate Buy" consensus and a $455.92 price target.

EarningsFinancial MarketsLife SciencesFinance
Published
10 Aug 2026 04:39
News subject
Earnings
Why this score
Operating growth
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 2.8% · 3.9d old
Duplicates
1 consolidated
#2450Tone
finance.yahoo.comDirect company coverageStored article

UnitedHealth (UNH) Commits $4M to Tennessee Health Hub Expansion

On July 29, UnitedHealth Group (NYSE:UNH) announced a $4 million commitment, funded through the United Health Foundation, to expand the University of Tennessee Health Sciences' health hub network from 5 locations to 13 across the state by the end of 2027, a buildout expected to reach 200,000 Tennessee residents. It's a modest sum for a company this size, but it lands as UnitedHealth works to repair a business that fell apart just a year earlier.UnitedHealth (UNH) Commits $4M to Tennessee Health Hub Expansion Bull Case: Margins Are Turning The Other Way The repair is showing up in the numbers.

CONSENSUS ESTIMATEConsensus EstimateEARNINGSEARNINGS PER SHAREEarningsEarnings Per Share
Published
09 Aug 2026 18:13
News subject
Earnings
Why this score
No clear positive or negative phrase
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 0.8% · 4.3d old
Duplicates
1 consolidated
#2550Tone
finance.yahoo.comDirect company coverageStored article

UnitedHealth Group (UNH) Leans On Optum And Medicare Advantage, Is The Stock Already Pricey?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. UnitedHealth Group (UNH) is back in focus after fresh attention on its Medicare Advantage and Optum Health businesses, which are helping offset pressure in commercial insurance and shaping how investors interpret the stock's recent moves. See our latest analysis for UnitedHealth Group. Over the past year, UnitedHealth Group's stock has combined a 21.01% year to date share price return with a 66.60% 1 year total shareholder return. The recent 1 month shar

DISCOUNTED CASH FLOWDiscounted Cash FlowEARNINGSEarningsHEALTHCAREHealthcare
Published
09 Aug 2026 06:14
News subject
Earnings
Why this score
No clear positive or negative phrase
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 0.7% · 4.8d old
Duplicates
1 consolidated
#2666Tone
MarketBeatDirect company coverageStored article

Gradient Investments LLC Sells 12,077 Shares of UnitedHealth Group Incorporated $UNH

Gradient Investments LLC reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 8.0% in the second quarter, selling 12,077 shares but still owning 139,811 shares valued at approximately $58.1 million. Despite this sale, institutional investors collectively own a significant 87.86% of UNH. Analysts maintain a "Moderate Buy" consensus rating with an average price target of $455.92, following strong quarterly earnings where UnitedHealth reported $6.38 EPS, beating estimates, and maintained its fiscal 2026 EPS guidance.

EarningsFinanceFinancial MarketsLife SciencesEconomy Macro
Published
08 Aug 2026 10:49
News subject
Earnings
Why this score
Operating growth
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 1.5% · 5.7d old
Duplicates
1 consolidated
#2781Tone
MarketBeatDirect company coverageStored article

UnitedHealth Group Incorporated $UNH Shares Bought by Teamwork Financial Advisors LLC

Teamwork Financial Advisors LLC significantly increased its stake in UnitedHealth Group (UNH) by 1,854.7% in the second quarter, now holding over 31,000 shares valued at $13.0 million. This comes as UnitedHealth reported strong quarterly earnings, beating estimates with $6.38 EPS on $112.03 billion revenue, and raised its quarterly dividend. Analysts maintain a "Moderate Buy" rating with an average price target of $455.92, despite a minor insider share sale by CEO Patrick Hugh Conway.

EarningsLife SciencesFinancial MarketsFinance
Published
08 Aug 2026 10:08
News subject
Earnings
Why this score
Operating growth, Capital returned, Institutional or insider buying
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 2.9% · 5.7d old
Duplicates
1 consolidated
#2857Tone
GuruFocusDirect company coverageStored article

UnitedHealth Group Inc (UNH) CEO Patrick Conway Sells 500 Shares

Patrick Conway, CEO of Optum (a UnitedHealth Group subsidiary), sold 500 shares of UnitedHealth Group Inc (UNH) on August 5, 2026, for approximately $205,000. This sale is part of a broader trend of insider selling at UNH over the past year, with no insider buys. Despite the selling, GuruFocus's GF Value suggests the stock is "Significantly Undervalued" at $604.41 compared to its trading price of $410, though its P/E ratio is higher than the industry median.

Financial MarketsEarningsLife SciencesFinance
Published
08 Aug 2026 08:08
News subject
Earnings
Why this score
Positive valuation view, Institutional or insider buying, Institutional or insider selling
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 1.5% · 5.8d old
Duplicates
1 consolidated
#2976Tone
MarketBeatDirect company coverageStored article

Aurora Investment Managers LLC. Invests $7.50 Million in UnitedHealth Group Incorporated $UNH

Aurora Investment Managers LLC. has acquired a new stake of 18,038 shares in UnitedHealth Group (NYSE:UNH), valued at approximately $7.5 million, making it their seventh-largest holding. The healthcare conglomerate has a "Moderate Buy" consensus rating from analysts with a $455.92 price target, and recently beat quarterly earnings estimates and raised its dividend. Institutional ownership remains high, though CEO Patrick Hugh Conway sold a small portion of his shares.

EarningsFinancial MarketsFinanceLife Sciences
Published
08 Aug 2026 07:38
News subject
Earnings
Why this score
Beat expectations, Capital returned, Institutional or insider selling
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 2.6% · 5.8d old
Duplicates
1 consolidated
#3082Tone
MarketBeatDirect company coverageStored article

UnitedHealth Group (NYSE:UNH) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen has upgraded UnitedHealth Group (NYSE:UNH) from a "hold" to a "buy" rating, contributing to a generally positive analyst outlook that rates the stock as a "Moderate Buy" with an average price target of $455.92. The company recently exceeded earnings estimates, reporting $6.38 per share against an expected $4.94, and maintained its fiscal 2026 earnings guidance. While institutional investors have significantly increased their positions, CEO Patrick Hugh Conway sold 500 shares for approximately $205,000.

EarningsFinancial MarketsLife Sciences
Published
08 Aug 2026 05:12
News subject
Analyst action
Why this score
Beat expectations, Improving financial comparison, Institutional or insider selling
Company focus
Shared story · 78%
How it is used
Direct company coverage
Weighted influence
Low · 1.1% · 5.9d old
Duplicates
1 consolidated

Earlier company news

UNH news archive

Showing 1-30 of 46 stored headlines

Stored newest first for historical research. It starts after the newest three pages above and then continues through older news. Each archive page is loaded only when it is opened.

Jul 17 2026
STATArchivedPositive tone

Despite earnings celebration, UnitedHealth signals more financial pain for employers

UnitedHealth Group exceeded Q2 earnings expectations, boosting its stock. However, statements from their earnings call suggest impending financial difficulties for American businesses and workers due to rising health insurance premiums. The article highlights that medical costs for UnitedHealthcare's employer clients increased by 11%.

EarningsLife SciencesEconomy MacroFinance
Published
17 Jul 2026 02:09
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Jul 17 2026
TradingViewArchivedPositive tone

UnitedHealth Group Q2 Earnings Call Highlights

UnitedHealth Group reported significantly higher second-quarter 2026 earnings, raising its full-year outlook despite elevated commercial medical costs. The company's adjusted EPS rose to $6.38, and total revenue reached $112 billion, with operating earnings up 55%. While Medicare Advantage performance improved, commercial margins are expected to take longer to recover, and Medicaid margins are projected to remain negative.

EarningsLife SciencesFinanceEconomy MacroTechnology
Published
17 Jul 2026 00:09
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Jul 16 2026
Healthcare DiveArchivedPositive tone

UnitedHealth raises 2026 guidance again as cost controls pay off in Q2

UnitedHealth reported a significant profit increase of 62% to $5.5 billion in Q2 2026, driven by improved earnings in its insurance and value-based care businesses. The company raised its adjusted earnings per share outlook for 2026 to $19.50-$20, exceeding analyst expectations, as cost control measures begin to yield results. While its commercial business faces challenges from arbitration processes and specialty drug costs, Optum Health saw "exceptional" results due to strategic network cuts and reduced risk-based membership.

EarningsLife Sciences
Published
16 Jul 2026 22:39
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Jul 16 2026
Seeking AlphaArchivedNegative tone

UnitedHealth Group Q2: The Real Test Begins Now (Downgrade) (NYSE:UNH)

UnitedHealth Group (UNH) reported a strong Q2 with a 50% YoY operating income increase and raised its FY 2026 EPS guidance to $19.5–$20, driven by effective cost initiatives and AI growth. Despite these operational improvements, the stock's valuation now exceeds its 5-year average P/E, diminishing the risk-reward profile. Consequently, the author has downgraded UNH from Buy to Hold, citing that current multiples and shareholder yield no longer support a bullish stance amidst sector complexities.

EarningsLife SciencesFinancial MarketsFinance
Published
16 Jul 2026 17:09
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Jul 16 2026
TradingKeyArchivedPositive tone

Unitedhealth Group Inc Stock (UNH) Moved Up by 4.61% on Jul 16: Key Drivers Unveiled

UnitedHealth Group Inc. (UNH) stock rose by 4.61% on July 16, driven by a strong second-quarter earnings report that exceeded Wall Street expectations. The company's effective management of its Medical Care Ratio and an upward revision of its full-year earnings guidance reassured investors and spurred institutional buying. UnitedHealth's diversified business model, including its Optum segment, and positive regulatory developments also contributed to the positive market sentiment.

EarningsFinancial MarketsLife Sciences
Published
16 Jul 2026 16:15
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Jul 16 2026
Modern HealthcareArchivedPositive tone

UnitedHealth reports quarterly profit above Wall Street estimates

UnitedHealth reported its second-quarter earnings, exceeding Wall Street's profit estimates. The article, authored by Ike Swetlitz from Bloomberg, highlights the strong financial performance of the healthcare giant. This report indicates a positive quarter for UnitedHealth.

EarningsLife Sciences
Published
16 Jul 2026 13:09
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Jul 16 2026
Modern HealthcareArchivedPositive tone

UnitedHealthcare recovery in swing but challenges remain

UnitedHealth Group reported a rise in earnings, primarily driven by the slow recovery of its UnitedHealthcare division. Despite this positive trend, the company still faces significant challenges in its operational landscape. The article highlights that while progress is being made, the path to full recovery for UnitedHealthcare is ongoing.

EarningsLife Sciences
Published
16 Jul 2026 12:43
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Jul 16 2026
Yahoo! Finance CanadaArchivedPositive tone

UnitedHealth Group boosts earnings outlook after stronger-than-expected Q2 results

UnitedHealth Group (NYSE:UNH) reported stronger-than-expected Q2 results, leading to a 5% share climb in post-market trading and an increased full-year adjusted earnings outlook. The company's adjusted earnings of $6.38 per share and revenue of $112 billion surpassed analyst expectations. UnitedHealth attributed its success to product design changes, improved medical management, and strategic investments, raising its 2026 adjusted earnings guidance to $19.50-$20 per share.

EarningsLife SciencesFinanceFinancial Markets
Published
16 Jul 2026 12:20
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Jul 16 2026
Star TribuneArchivedNeutral tone

UnitedHealth blasts health care providers’ ‘egregious’ awards under No Surprises Act

UnitedHealth Group is criticizing the No Surprises Act's arbitration process, claiming health care providers are receiving "egregious" and inflated awards, significantly driving up costs for employer health plans. The company highlights instances where surgical assistants allegedly received payments far exceeding standard rates, adding billions to overall health system costs. While UnitedHealth calls for reform, providers argue they are winning disputes because insurers are underpaying, not due to corruption.

EarningsLife SciencesEconomy Fiscal
Published
16 Jul 2026 10:43
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Jul 16 2026
Seeking AlphaArchivedPositive tone

UnitedHealth rallies on upbeat forecast; these ETFs have the highest exposure (UNH:NYSE)

UnitedHealth Group (UNH) has raised its full-year profit outlook after exceeding Wall Street's second-quarter earnings expectations. The company now forecasts adjusted earnings of $19.50 to $20.00 per share for 2025, an increase from its previous guidance, signaling a sustained recovery after a significant setback. This positive forecast has led to a rally in UnitedHealth's stock.

EarningsLife SciencesFinancial Markets
Published
16 Jul 2026 07:38
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Jul 16 2026
CNBCArchivedPositive tone

UnitedHealth blows past estimates, hikes earnings outlook as it reins in costs

UnitedHealth Group (UNH) significantly surpassed Q2 earnings estimates and raised its full-year profit outlook for 2026, benefiting from better management of high medical costs and a $1.5 billion investment in AI. The company reported adjusted earnings of $6.38 per share, against an expected $4.90, and now anticipates 2026 adjusted earnings of $19.50 to $20 per share. This positive performance is largely attributed to strategies like shrinking membership, exiting unprofitable contracts, and leveraging AI to streamline operations and detect fraud, even as medical costs remain elevated.

EarningsLife SciencesFinanceTechnology
Published
16 Jul 2026 06:56
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Jul 15 2026
Ad-hoc-news.deArchivedNeutral tone

UnitedHealth Group stock holds steady as diversified health benefits and Optum growth shape the long-term story

UnitedHealth Group's stock reflects a diversified model combining health insurance and care delivery, driven by its Optum unit and broad US market exposure. The company offers a mix of defensive cash flows from its insurance segment and growth potential through Optum's health services. Its integrated approach and scale provide operating efficiencies and resilience against economic cycles, making it a core holding for investors seeking exposure to US healthcare.

Life SciencesEarningsFinancial MarketsFinance
Published
15 Jul 2026 20:16
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Jul 15 2026
InsuranceNewsNetArchivedNegative tone

Appeals court tosses lawsuit accusing UnitedHealth of misleading seniors

A federal appeals court upheld a lower court's decision to dismiss a lawsuit against UnitedHealth Group, which accused the company of deceptively marketing its Medicare Advantage plans. The 9th U.S. Circuit Court of Appeals ruled that state laws cited by the plaintiffs, who alleged aggressive and misleading marketing tactics that prioritized profitability over transparency, are preempted by federal regulations concerning Medicare Advantage plan marketing. This decision affirms that such marketing falls under extensive regulatory oversight by the Centers for Medicare & Medicaid Services (CMS).

FinanceLife Sciences
Published
15 Jul 2026 20:11
Catalyst
Regulatory and legal
Coverage
Direct company
Duplicates
1 consolidated
Jul 15 2026
Market sourceArchivedPositive tone

Will UnitedHealth (UNH) Beat Estimates Again in Its Next Earnings Report?

UnitedHealth Group (UNH) is poised to continue its streak of beating earnings estimates in its upcoming report, according to Zacks Equity Research. The company has a strong record of surpassing estimates, averaging 6.44% over the last two quarters, and currently holds a positive Zacks Earnings ESP of +7.71% combined with a Zacks Rank #2 (Buy). This combination suggests a high probability of another positive surprise when its next earnings report is released on July 16, 2026.

EarningsLife SciencesFinancial MarketsFinance
Published
15 Jul 2026 17:39
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Jul 15 2026
HEALTH CARE un-coveredArchivedNeutral tone

Bought, Then Shuttered: What UnitedHealth Group did with the Behavioral Health Clinics it Acquired

UnitedHealth Group's Optum acquired hundreds of community mental-health practices and then closed more than half of them within three years, often with little warning to patients. This pattern affects access to critical in-person behavioral health services, including specialized care for eating disorders and autism. The article reveals that Optum has simultaneously invested in virtual and data-driven behavioral health startups, suggesting a shift towards scalable, remote services while divesting from labor-intensive in-person clinics.

Life SciencesMergers And AcquisitionsFinance
Published
15 Jul 2026 12:39
Catalyst
Deals and strategy
Coverage
Direct company
Duplicates
1 consolidated
Jul 15 2026
Simply Wall StreetArchivedNeutral tone

How Expanded Coverage for Guardant’s Shield Test Will Impact UnitedHealth Group (UNH) Investors

UnitedHealth Group's decision to cover Guardant Health's Shield blood test for colorectal cancer screening for roughly 40 million members over 45 aligns with its focus on preventive care. While this move supports UnitedHealth's long-term investment narrative through innovation and efficiency, it's overshadowed by ongoing regulatory scrutiny, particularly from the U.S. Department of Justice's antitrust investigation into its Claritev unit. Investors should weigh the benefits of preventive care against potential tight constraints on pricing and network strategies.

EarningsFinancial MarketsLife Sciences
Published
15 Jul 2026 06:11
Catalyst
Earnings
Coverage
Direct company
Duplicates
2 consolidated

Provider matches checked

Provider mentions not used in the score

17 not scored

A news provider linked these stories to UNH, but the headline and available text are not mainly about UnitedHealth Group Incorporated. They are kept here for transparency and do not affect the score, confidence, history or wider market totals.

Provider mentions are kept separate

Open the list to see which provider matches were checked and left out of UNH sentiment.

Open provider mentions

How the page works

How to read the score

The score shows direction

It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.

Confidence is separate

Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.

Price is confirmation

Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.

What the page does

It measures news already published. It is not a forecast, recommendation or price target.

Evidence context